PMV Pharmaceuticals, Inc. (PMVP)
NASDAQ: PMVP · Real-Time Price · USD
1.640
+0.010 (0.61%)
Nov 4, 2024, 4:00 PM EST - Market closed
PMV Pharmaceuticals Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| TTM
| FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
| Jun '24 Jun 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
| Selling, General & Admin | 22.14 | 24.25 | 25.05 | 21.8 | 11.01 | 5.88 | |
| Research & Development | 54.15 | 55.89 | 51.99 | 36.49 | 23.93 | 20.76 | |
| Operating Expenses | 76.29 | 80.13 | 77.04 | 58.29 | 34.94 | 26.64 | |
| Operating Income | -76.29 | -80.13 | -77.04 | -58.29 | -34.94 | -26.64 | |
| Interest & Investment Income | 11.9 | 11.17 | 3.63 | 0.45 | 0.65 | 1.3 | |
| Other Non Operating Income (Expenses) | -0.04 | 0 | 0.09 | 0.02 | -0.14 | -0.01 | |
| Pretax Income | -65.05 | -68.96 | -73.33 | -57.82 | -34.43 | -25.34 | |
| Income Tax Expense | -16.18 | 0 | -0.01 | 0.02 | 0.01 | 0.01 | |
| Net Income | -48.88 | -68.96 | -73.32 | -57.85 | -34.44 | -25.35 | |
| Net Income to Common | -48.88 | -68.96 | -73.32 | -57.85 | -34.44 | -25.35 | |
| Shares Outstanding (Basic) | 51 | 48 | 46 | 45 | 14 | 3 | |
| Shares Outstanding (Diluted) | 51 | 48 | 46 | 45 | 14 | 3 | |
| Shares Change (YoY) | 11.19% | 5.31% | 1.01% | 214.23% | 373.26% | 0.76% | |
| EPS (Basic) | -0.96 | -1.44 | -1.61 | -1.28 | -2.40 | -8.35 | |
| EPS (Diluted) | -0.96 | -1.44 | -1.61 | -1.28 | -2.40 | -8.35 | |
| Free Cash Flow | -46.37 | -56.62 | -71.74 | -47.92 | -32.89 | -22.17 | |
| Free Cash Flow Per Share | -0.91 | -1.18 | -1.57 | -1.06 | -2.29 | -7.31 | |
| EBITDA | -74.84 | -78.88 | -76.73 | -57.99 | -34.62 | -26.25 | |
| D&A For EBITDA | 1.45 | 1.26 | 0.32 | 0.31 | 0.32 | 0.39 | |
| EBIT | -76.29 | -80.13 | -77.04 | -58.29 | -34.94 | -26.64 | |
Source: S&P Capital IQ. Standard template.
Financial Sources.